Collections:
Other Resources:
DOI: 10.1002/cpt.3688
Paper Summary:
Title: Real‐World Evidence in New Drug and Biologics License Application Approvals During Fiscal Years 2020–2022
Author(s): Innes, Gabriel K. (author);Smith, Kimberly A. (author);Kuzucan, Aida (author);Li, Jie (author);Rivera, Donna (author);Panagiotou, Orestis A. (author);Concato, John (author)
Year: 2025
DOI: 10.1002/cpt.3688
URL: https://doi.org/10.1002/cpt.3688
Download Paper from Sci-Hub:
✍: FYIcenter.com
2025-07-14, ∼1027👍, 0💬
Popular Posts:
Paper Summary: Title: Promoted catalytic potential in sulfides oxidation and biological screening of...
How to use XML API URL, doi.crossref.org/servlet /query?qdata={xml},for DOI-to-metadata query? XML A...
Paper Summary: Title: The effect of environmental and social performance on the stock performance of...
Paper Summary: Title: Assessing SRI fund performance research: Best practices in empirical analysis ...
How to use OA Web service at ncbi.nlm.nih.gov/pmc/uti ls/oa/oa.fcgi?PMC OA Web Service at ncbi.nlm.n...